Cleared Traditional

K133582 - HEMOSIL D-DIMER HS 500 CONTROL

K133582 is an FDA 510(k) clearance for HEMOSIL D-DIMER HS 500 CONTROL, manufactured by Instrumentation Laboratory. The device is a Class 2 Hematology device with product code GGN cleared through the Traditional 510(k) pathway after a 267-day FDA review.

K133582 · Instrumentation Laboratory · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2014
Decision
267d
Days
Class 2
Risk

K133582 is an FDA 510(k) clearance for the HEMOSIL D-DIMER HS 500 CONTROL. Classified as Plasma, Coagulation Control (product code GGN), Class II - Special Controls.

Submitted by Instrumentation Laboratory (Bedford, US). The FDA issued a Cleared decision on August 15, 2014 after a review of 267 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Instrumentation Laboratory devices

FDA 510(k) Submission Details - K133582

510(k) Number K133582 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 21, 2013
Decision Date August 15, 2014
Days to Decision 267 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 113d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGN Device Classification - Class 2, Special Controls

Product Code GGN Plasma, Coagulation Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGN Plasma, Coagulation Control

All 95
Devices cleared under the same product code (GGN) and FDA review panel - the closest regulatory comparables to K133582.
VALIDATE D-Dimer Calibration Verification/Linearity Test Kit
K152961 · Maine Standards Company, LLC · Jun 2016
VisuCon-F Low Fibrinogen Control Plasma
K150144 · Affinity Biologicals, Inc. · Mar 2016
POOL NORM
K142132 · Diagnostics Stago S.A.S. · Dec 2014
DIRECTCHECK CONTROL FOR HEMOCHRON JR. MICROCOAGULATION SYSTEMS ACT-LR CUVETTE DIRECTCHECK CONTROLS FOR HEMOCHRON JR. MIC
K120977 · International Technidyne Corp. · Jul 2013
I-STAT PT CONTROL LEVIEL 1 I-STAT PT CONTROL LEVEL 2
K120900 · Cliniqa Corporation · May 2013
STA- COAG CONTROL (N+ABN) PLUS
K120014 · Diagnostica Stago, Inc. · Mar 2013